drugset / Trial / NCT00157326
Tadalafil in Subjects With Mild to Moderate Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
Purpose: The primary objective of this study is to evaluate the efficacy and safety of tadalafil when administered once daily at doses of 5 and 20 mg to adult subjects for 8 weeks with mild to moderate hypertension.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tadalafil | Small molecule | 5 mg | — |
| Subject | Tadalafil | Small molecule | 20 mg | — |